Company Alipharm Srl with Fiscal Code 16572238
recorded a turnover of 2024 of
218.584,
with a net profit of
3.279
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Alipharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
105.543
-
-
157.814
106.972
78.086
182.228
207.870
217.159
218.584
Total Income - EUR
105.852
-
-
165.616
106.972
78.924
182.356
207.872
217.161
218.585
Total Expenses - EUR
97.359
-
-
135.533
98.464
77.526
163.166
153.619
212.454
209.988
Gross Profit/Loss - EUR
8.493
-
-
30.083
8.508
1.398
19.190
54.253
4.707
8.597
Net Profit/Loss - EUR
6.394
-
-
28.427
7.439
572
17.586
52.216
1.992
3.279
Employees
3
-
-
3
3
2
3
3
2
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 1.2%, from 217.159 euro in the year 2023, to 218.584 euro in 2024.
The Net Profit increased by 1.297 euro, from 1.992 euro in 2023, to 3.279 in the last year.
Check the financial reports for the company - Alipharm Srl
Financial Rating - ALIPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Alipharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Alipharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Alipharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
160.042 euro in 2024 which includes Inventories of
70.998 euro, Receivables of
56.000 euro and cash availability of
33.043 euro.
The company's Equity was valued at
81.694 euro, while total Liabilities amounted to
79.848 euro.
Equity increased by 3.279 euro, from 78.856 euro in 2023, to 81.694 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Alipharm Srl